nodes	percent_of_prediction	percent_of_DWPC	metapath
Diazoxide—KCNMA1—pulmonary artery—systemic scleroderma	0.0659	0.252	CbGeAlD
Diazoxide—KCNMA1—artery—systemic scleroderma	0.0244	0.0933	CbGeAlD
Diazoxide—KCNMA1—blood vessel—systemic scleroderma	0.019	0.0727	CbGeAlD
Diazoxide—GLUL—connective tissue—systemic scleroderma	0.0105	0.0402	CbGeAlD
Diazoxide—GLUL—smooth muscle tissue—systemic scleroderma	0.00962	0.0367	CbGeAlD
Diazoxide—GLUL—skin of body—systemic scleroderma	0.0095	0.0363	CbGeAlD
Diazoxide—KCNMA1—smooth muscle tissue—systemic scleroderma	0.00893	0.0341	CbGeAlD
Diazoxide—SLC12A3—lung—systemic scleroderma	0.00851	0.0325	CbGeAlD
Diazoxide—ABCC8—smooth muscle tissue—systemic scleroderma	0.00832	0.0318	CbGeAlD
Diazoxide—GLUL—digestive system—systemic scleroderma	0.0076	0.029	CbGeAlD
Diazoxide—GLUL—tendon—systemic scleroderma	0.00723	0.0276	CbGeAlD
Diazoxide—KCNJ11—tendon—systemic scleroderma	0.00679	0.0259	CbGeAlD
Diazoxide—GLUL—lung—systemic scleroderma	0.00634	0.0242	CbGeAlD
Diazoxide—ATP1A1—connective tissue—systemic scleroderma	0.00627	0.0239	CbGeAlD
Diazoxide—KCNMA1—lung—systemic scleroderma	0.00589	0.0225	CbGeAlD
Diazoxide—ATP1A1—smooth muscle tissue—systemic scleroderma	0.00574	0.0219	CbGeAlD
Diazoxide—ATP1A1—skin of body—systemic scleroderma	0.00566	0.0216	CbGeAlD
Diazoxide—CA1—digestive system—systemic scleroderma	0.00535	0.0204	CbGeAlD
Diazoxide—CA2—connective tissue—systemic scleroderma	0.0048	0.0183	CbGeAlD
Diazoxide—ATP1A1—digestive system—systemic scleroderma	0.00453	0.0173	CbGeAlD
Diazoxide—CA1—lung—systemic scleroderma	0.00447	0.0171	CbGeAlD
Diazoxide—CA2—smooth muscle tissue—systemic scleroderma	0.00439	0.0168	CbGeAlD
Diazoxide—CA2—skin of body—systemic scleroderma	0.00434	0.0166	CbGeAlD
Diazoxide—ATP1A1—tendon—systemic scleroderma	0.00431	0.0165	CbGeAlD
Diazoxide—ATP1A1—lung—systemic scleroderma	0.00378	0.0144	CbGeAlD
Diazoxide—CA2—digestive system—systemic scleroderma	0.00347	0.0132	CbGeAlD
Diazoxide—CA2—tendon—systemic scleroderma	0.0033	0.0126	CbGeAlD
Diazoxide—CA2—lung—systemic scleroderma	0.0029	0.0111	CbGeAlD
Diazoxide—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00178	0.00242	CcSEcCtD
Diazoxide—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00241	CcSEcCtD
Diazoxide—Flushing—Lisinopril—systemic scleroderma	0.00177	0.0024	CcSEcCtD
Diazoxide—Malaise—Leflunomide—systemic scleroderma	0.00175	0.00236	CcSEcCtD
Diazoxide—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00174	0.00236	CcSEcCtD
Diazoxide—Insomnia—Captopril—systemic scleroderma	0.00173	0.00235	CcSEcCtD
Diazoxide—Leukopenia—Leflunomide—systemic scleroderma	0.00173	0.00235	CcSEcCtD
Diazoxide—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00173	0.00234	CcSEcCtD
Diazoxide—Abdominal pain—Mometasone—systemic scleroderma	0.00172	0.00234	CcSEcCtD
Diazoxide—Body temperature increased—Mometasone—systemic scleroderma	0.00172	0.00234	CcSEcCtD
Diazoxide—Discomfort—Azathioprine—systemic scleroderma	0.00172	0.00234	CcSEcCtD
Diazoxide—Paraesthesia—Captopril—systemic scleroderma	0.00172	0.00233	CcSEcCtD
Diazoxide—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.00171	0.00232	CcSEcCtD
Diazoxide—Palpitations—Leflunomide—systemic scleroderma	0.00171	0.00232	CcSEcCtD
Diazoxide—Purpura—Prednisone—systemic scleroderma	0.0017	0.00231	CcSEcCtD
Diazoxide—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00168	0.00228	CcSEcCtD
Diazoxide—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00167	0.00227	CcSEcCtD
Diazoxide—Dizziness—Pentoxifylline—systemic scleroderma	0.00167	0.00227	CcSEcCtD
Diazoxide—Hypertension—Leflunomide—systemic scleroderma	0.00167	0.00226	CcSEcCtD
Diazoxide—Decreased appetite—Captopril—systemic scleroderma	0.00167	0.00226	CcSEcCtD
Diazoxide—Malaise—Mycophenolic acid—systemic scleroderma	0.00167	0.00226	CcSEcCtD
Diazoxide—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00165	0.00224	CcSEcCtD
Diazoxide—Chest pain—Leflunomide—systemic scleroderma	0.00165	0.00223	CcSEcCtD
Diazoxide—Anxiety—Leflunomide—systemic scleroderma	0.00164	0.00222	CcSEcCtD
Diazoxide—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00164	0.00222	CcSEcCtD
Diazoxide—Palpitations—Mycophenolic acid—systemic scleroderma	0.00163	0.00221	CcSEcCtD
Diazoxide—Discomfort—Leflunomide—systemic scleroderma	0.00163	0.00221	CcSEcCtD
Diazoxide—Vomiting—Pentoxifylline—systemic scleroderma	0.00161	0.00218	CcSEcCtD
Diazoxide—Lymphadenopathy—Methotrexate—systemic scleroderma	0.00161	0.00218	CcSEcCtD
Diazoxide—Rash—Pentoxifylline—systemic scleroderma	0.00159	0.00216	CcSEcCtD
Diazoxide—Hypertension—Mycophenolic acid—systemic scleroderma	0.00159	0.00216	CcSEcCtD
Diazoxide—Dermatitis—Pentoxifylline—systemic scleroderma	0.00159	0.00216	CcSEcCtD
Diazoxide—Headache—Pentoxifylline—systemic scleroderma	0.00158	0.00215	CcSEcCtD
Diazoxide—Feeling abnormal—Captopril—systemic scleroderma	0.00158	0.00214	CcSEcCtD
Diazoxide—Chest pain—Mycophenolic acid—systemic scleroderma	0.00157	0.00213	CcSEcCtD
Diazoxide—Vision blurred—Lisinopril—systemic scleroderma	0.00157	0.00212	CcSEcCtD
Diazoxide—Gastrointestinal pain—Captopril—systemic scleroderma	0.00157	0.00212	CcSEcCtD
Diazoxide—Anxiety—Mycophenolic acid—systemic scleroderma	0.00157	0.00212	CcSEcCtD
Diazoxide—Asthenia—Mometasone—systemic scleroderma	0.00157	0.00212	CcSEcCtD
Diazoxide—Hypotension—Azathioprine—systemic scleroderma	0.00156	0.00212	CcSEcCtD
Diazoxide—Discomfort—Mycophenolic acid—systemic scleroderma	0.00155	0.0021	CcSEcCtD
Diazoxide—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00155	0.0021	CcSEcCtD
Diazoxide—Pruritus—Mometasone—systemic scleroderma	0.00154	0.00209	CcSEcCtD
Diazoxide—Ill-defined disorder—Lisinopril—systemic scleroderma	0.00154	0.00209	CcSEcCtD
Diazoxide—Tachycardia—Leflunomide—systemic scleroderma	0.00154	0.00209	CcSEcCtD
Diazoxide—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00153	0.00207	CcSEcCtD
Diazoxide—Body temperature increased—Captopril—systemic scleroderma	0.00152	0.00205	CcSEcCtD
Diazoxide—Abdominal pain—Captopril—systemic scleroderma	0.00152	0.00205	CcSEcCtD
Diazoxide—Oedema—Mycophenolic acid—systemic scleroderma	0.00151	0.00204	CcSEcCtD
Diazoxide—Anorexia—Leflunomide—systemic scleroderma	0.00151	0.00204	CcSEcCtD
Diazoxide—Nausea—Pentoxifylline—systemic scleroderma	0.0015	0.00204	CcSEcCtD
Diazoxide—Malaise—Lisinopril—systemic scleroderma	0.0015	0.00203	CcSEcCtD
Diazoxide—Diarrhoea—Mometasone—systemic scleroderma	0.00149	0.00202	CcSEcCtD
Diazoxide—Hypokalaemia—Prednisone—systemic scleroderma	0.00149	0.00202	CcSEcCtD
Diazoxide—Leukopenia—Lisinopril—systemic scleroderma	0.00149	0.00202	CcSEcCtD
Diazoxide—Hypotension—Leflunomide—systemic scleroderma	0.00148	0.002	CcSEcCtD
Diazoxide—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00148	0.002	CcSEcCtD
Diazoxide—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00147	0.00199	CcSEcCtD
Diazoxide—Palpitations—Lisinopril—systemic scleroderma	0.00147	0.00199	CcSEcCtD
Diazoxide—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00146	0.00197	CcSEcCtD
Diazoxide—Anorexia—Mycophenolic acid—systemic scleroderma	0.00144	0.00195	CcSEcCtD
Diazoxide—Insomnia—Leflunomide—systemic scleroderma	0.00143	0.00194	CcSEcCtD
Diazoxide—Paraesthesia—Leflunomide—systemic scleroderma	0.00142	0.00192	CcSEcCtD
Diazoxide—Chest pain—Lisinopril—systemic scleroderma	0.00142	0.00192	CcSEcCtD
Diazoxide—Anxiety—Lisinopril—systemic scleroderma	0.00141	0.00191	CcSEcCtD
Diazoxide—Hypotension—Mycophenolic acid—systemic scleroderma	0.00141	0.00191	CcSEcCtD
Diazoxide—Discomfort—Lisinopril—systemic scleroderma	0.0014	0.0019	CcSEcCtD
Diazoxide—Pancreatitis—Prednisone—systemic scleroderma	0.00139	0.00188	CcSEcCtD
Diazoxide—Vomiting—Mometasone—systemic scleroderma	0.00139	0.00188	CcSEcCtD
Diazoxide—Feeling abnormal—Azathioprine—systemic scleroderma	0.00138	0.00187	CcSEcCtD
Diazoxide—Rash—Mometasone—systemic scleroderma	0.00138	0.00186	CcSEcCtD
Diazoxide—Asthenia—Captopril—systemic scleroderma	0.00138	0.00186	CcSEcCtD
Diazoxide—Dermatitis—Mometasone—systemic scleroderma	0.00137	0.00186	CcSEcCtD
Diazoxide—Decreased appetite—Leflunomide—systemic scleroderma	0.00137	0.00186	CcSEcCtD
Diazoxide—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00137	0.00185	CcSEcCtD
Diazoxide—Headache—Mometasone—systemic scleroderma	0.00137	0.00185	CcSEcCtD
Diazoxide—Insomnia—Mycophenolic acid—systemic scleroderma	0.00136	0.00185	CcSEcCtD
Diazoxide—Oedema—Lisinopril—systemic scleroderma	0.00136	0.00184	CcSEcCtD
Diazoxide—Pruritus—Captopril—systemic scleroderma	0.00136	0.00184	CcSEcCtD
Diazoxide—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00135	0.00183	CcSEcCtD
Diazoxide—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00183	CcSEcCtD
Diazoxide—Pain—Leflunomide—systemic scleroderma	0.00135	0.00183	CcSEcCtD
Diazoxide—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00133	0.0018	CcSEcCtD
Diazoxide—Tachycardia—Lisinopril—systemic scleroderma	0.00132	0.00179	CcSEcCtD
Diazoxide—Abdominal pain—Azathioprine—systemic scleroderma	0.00132	0.00179	CcSEcCtD
Diazoxide—Body temperature increased—Azathioprine—systemic scleroderma	0.00132	0.00179	CcSEcCtD
Diazoxide—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00131	0.00178	CcSEcCtD
Diazoxide—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00131	0.00178	CcSEcCtD
Diazoxide—Diarrhoea—Captopril—systemic scleroderma	0.00131	0.00178	CcSEcCtD
Diazoxide—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00131	0.00177	CcSEcCtD
Diazoxide—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.0013	0.00177	CcSEcCtD
Diazoxide—Feeling abnormal—Leflunomide—systemic scleroderma	0.0013	0.00176	CcSEcCtD
Diazoxide—Nausea—Mometasone—systemic scleroderma	0.0013	0.00176	CcSEcCtD
Diazoxide—Anorexia—Lisinopril—systemic scleroderma	0.00129	0.00175	CcSEcCtD
Diazoxide—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00129	0.00175	CcSEcCtD
Diazoxide—Weight increased—Prednisone—systemic scleroderma	0.00129	0.00175	CcSEcCtD
Diazoxide—Pain—Mycophenolic acid—systemic scleroderma	0.00129	0.00175	CcSEcCtD
Diazoxide—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00129	0.00174	CcSEcCtD
Diazoxide—Hyperglycaemia—Prednisone—systemic scleroderma	0.00128	0.00173	CcSEcCtD
Diazoxide—Hypotension—Lisinopril—systemic scleroderma	0.00127	0.00172	CcSEcCtD
Diazoxide—Dizziness—Captopril—systemic scleroderma	0.00127	0.00172	CcSEcCtD
Diazoxide—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00126	0.0017	CcSEcCtD
Diazoxide—Abdominal pain—Leflunomide—systemic scleroderma	0.00125	0.00169	CcSEcCtD
Diazoxide—Body temperature increased—Leflunomide—systemic scleroderma	0.00125	0.00169	CcSEcCtD
Diazoxide—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00124	0.00168	CcSEcCtD
Diazoxide—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00168	CcSEcCtD
Diazoxide—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00167	CcSEcCtD
Diazoxide—Hypersensitivity—Azathioprine—systemic scleroderma	0.00123	0.00167	CcSEcCtD
Diazoxide—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00123	0.00167	CcSEcCtD
Diazoxide—Insomnia—Lisinopril—systemic scleroderma	0.00123	0.00166	CcSEcCtD
Diazoxide—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00166	CcSEcCtD
Diazoxide—Paraesthesia—Lisinopril—systemic scleroderma	0.00122	0.00165	CcSEcCtD
Diazoxide—Vomiting—Captopril—systemic scleroderma	0.00122	0.00165	CcSEcCtD
Diazoxide—Rash—Captopril—systemic scleroderma	0.00121	0.00164	CcSEcCtD
Diazoxide—Dermatitis—Captopril—systemic scleroderma	0.00121	0.00164	CcSEcCtD
Diazoxide—Headache—Captopril—systemic scleroderma	0.0012	0.00163	CcSEcCtD
Diazoxide—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00119	0.00161	CcSEcCtD
Diazoxide—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00119	0.00161	CcSEcCtD
Diazoxide—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00161	CcSEcCtD
Diazoxide—Decreased appetite—Lisinopril—systemic scleroderma	0.00118	0.0016	CcSEcCtD
Diazoxide—Eosinophilia—Methotrexate—systemic scleroderma	0.00117	0.00159	CcSEcCtD
Diazoxide—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00158	CcSEcCtD
Diazoxide—Hypersensitivity—Leflunomide—systemic scleroderma	0.00116	0.00158	CcSEcCtD
Diazoxide—Pancreatitis—Methotrexate—systemic scleroderma	0.00116	0.00157	CcSEcCtD
Diazoxide—Pain—Lisinopril—systemic scleroderma	0.00116	0.00157	CcSEcCtD
Diazoxide—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00157	CcSEcCtD
Diazoxide—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00156	CcSEcCtD
Diazoxide—Diarrhoea—Azathioprine—systemic scleroderma	0.00114	0.00155	CcSEcCtD
Diazoxide—Haemoglobin—Prednisone—systemic scleroderma	0.00114	0.00155	CcSEcCtD
Diazoxide—Nausea—Captopril—systemic scleroderma	0.00114	0.00154	CcSEcCtD
Diazoxide—Abdominal discomfort—Methotrexate—systemic scleroderma	0.00114	0.00154	CcSEcCtD
Diazoxide—Haemorrhage—Prednisone—systemic scleroderma	0.00113	0.00154	CcSEcCtD
Diazoxide—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00154	CcSEcCtD
Diazoxide—Asthenia—Leflunomide—systemic scleroderma	0.00113	0.00154	CcSEcCtD
Diazoxide—Feeling abnormal—Lisinopril—systemic scleroderma	0.00112	0.00152	CcSEcCtD
Diazoxide—Pruritus—Leflunomide—systemic scleroderma	0.00112	0.00151	CcSEcCtD
Diazoxide—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00151	CcSEcCtD
Diazoxide—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00111	0.0015	CcSEcCtD
Diazoxide—Dizziness—Azathioprine—systemic scleroderma	0.00111	0.0015	CcSEcCtD
Diazoxide—Asthenia—Mycophenolic acid—systemic scleroderma	0.00108	0.00146	CcSEcCtD
Diazoxide—Diarrhoea—Leflunomide—systemic scleroderma	0.00108	0.00146	CcSEcCtD
Diazoxide—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00146	CcSEcCtD
Diazoxide—Body temperature increased—Lisinopril—systemic scleroderma	0.00107	0.00145	CcSEcCtD
Diazoxide—Abdominal pain—Lisinopril—systemic scleroderma	0.00107	0.00145	CcSEcCtD
Diazoxide—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00145	CcSEcCtD
Diazoxide—Pruritus—Mycophenolic acid—systemic scleroderma	0.00107	0.00144	CcSEcCtD
Diazoxide—Vomiting—Azathioprine—systemic scleroderma	0.00106	0.00144	CcSEcCtD
Diazoxide—Rash—Azathioprine—systemic scleroderma	0.00105	0.00143	CcSEcCtD
Diazoxide—Dermatitis—Azathioprine—systemic scleroderma	0.00105	0.00143	CcSEcCtD
Diazoxide—Flushing—Prednisone—systemic scleroderma	0.00105	0.00143	CcSEcCtD
Diazoxide—Headache—Azathioprine—systemic scleroderma	0.00105	0.00142	CcSEcCtD
Diazoxide—Dizziness—Leflunomide—systemic scleroderma	0.00104	0.00142	CcSEcCtD
Diazoxide—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.00103	0.0014	CcSEcCtD
Diazoxide—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00103	0.0014	CcSEcCtD
Diazoxide—Pain—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00138	CcSEcCtD
Diazoxide—Sweating—Methotrexate—systemic scleroderma	0.00101	0.00137	CcSEcCtD
Diazoxide—Haematuria—Methotrexate—systemic scleroderma	0.00101	0.00136	CcSEcCtD
Diazoxide—Vomiting—Leflunomide—systemic scleroderma	0.001	0.00136	CcSEcCtD
Diazoxide—Hypersensitivity—Lisinopril—systemic scleroderma	0.001	0.00135	CcSEcCtD
Diazoxide—Dizziness—Mycophenolic acid—systemic scleroderma	0.000996	0.00135	CcSEcCtD
Diazoxide—Rash—Leflunomide—systemic scleroderma	0.000996	0.00135	CcSEcCtD
Diazoxide—Dermatitis—Leflunomide—systemic scleroderma	0.000995	0.00135	CcSEcCtD
Diazoxide—Nausea—Azathioprine—systemic scleroderma	0.000994	0.00135	CcSEcCtD
Diazoxide—Headache—Leflunomide—systemic scleroderma	0.00099	0.00134	CcSEcCtD
Diazoxide—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00098	0.00133	CcSEcCtD
Diazoxide—Asthenia—Lisinopril—systemic scleroderma	0.000974	0.00132	CcSEcCtD
Diazoxide—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000972	0.00132	CcSEcCtD
Diazoxide—Pruritus—Lisinopril—systemic scleroderma	0.00096	0.0013	CcSEcCtD
Diazoxide—Vomiting—Mycophenolic acid—systemic scleroderma	0.000958	0.0013	CcSEcCtD
Diazoxide—Haemoglobin—Methotrexate—systemic scleroderma	0.000953	0.00129	CcSEcCtD
Diazoxide—Rash—Mycophenolic acid—systemic scleroderma	0.00095	0.00129	CcSEcCtD
Diazoxide—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000949	0.00129	CcSEcCtD
Diazoxide—Haemorrhage—Methotrexate—systemic scleroderma	0.000948	0.00128	CcSEcCtD
Diazoxide—Headache—Mycophenolic acid—systemic scleroderma	0.000944	0.00128	CcSEcCtD
Diazoxide—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00127	CcSEcCtD
Diazoxide—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00127	CcSEcCtD
Diazoxide—Nausea—Leflunomide—systemic scleroderma	0.000938	0.00127	CcSEcCtD
Diazoxide—Vision blurred—Prednisone—systemic scleroderma	0.000931	0.00126	CcSEcCtD
Diazoxide—Diarrhoea—Lisinopril—systemic scleroderma	0.000929	0.00126	CcSEcCtD
Diazoxide—Ill-defined disorder—Prednisone—systemic scleroderma	0.000916	0.00124	CcSEcCtD
Diazoxide—Dizziness—Lisinopril—systemic scleroderma	0.000898	0.00122	CcSEcCtD
Diazoxide—Nausea—Mycophenolic acid—systemic scleroderma	0.000895	0.00121	CcSEcCtD
Diazoxide—Malaise—Prednisone—systemic scleroderma	0.000891	0.00121	CcSEcCtD
Diazoxide—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000876	0.00119	CcSEcCtD
Diazoxide—Vomiting—Lisinopril—systemic scleroderma	0.000863	0.00117	CcSEcCtD
Diazoxide—Rash—Lisinopril—systemic scleroderma	0.000856	0.00116	CcSEcCtD
Diazoxide—Dermatitis—Lisinopril—systemic scleroderma	0.000855	0.00116	CcSEcCtD
Diazoxide—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000853	0.00116	CcSEcCtD
Diazoxide—Hypertension—Prednisone—systemic scleroderma	0.000853	0.00116	CcSEcCtD
Diazoxide—Headache—Lisinopril—systemic scleroderma	0.00085	0.00115	CcSEcCtD
Diazoxide—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000841	0.00114	CcSEcCtD
Diazoxide—Anxiety—Prednisone—systemic scleroderma	0.000838	0.00114	CcSEcCtD
Diazoxide—Discomfort—Prednisone—systemic scleroderma	0.000831	0.00113	CcSEcCtD
Diazoxide—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000814	0.0011	CcSEcCtD
Diazoxide—Nausea—Lisinopril—systemic scleroderma	0.000806	0.00109	CcSEcCtD
Diazoxide—Oedema—Prednisone—systemic scleroderma	0.000806	0.00109	CcSEcCtD
Diazoxide—Tachycardia—Prednisone—systemic scleroderma	0.000787	0.00107	CcSEcCtD
Diazoxide—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000786	0.00107	CcSEcCtD
Diazoxide—Hyperhidrosis—Prednisone—systemic scleroderma	0.000779	0.00106	CcSEcCtD
Diazoxide—Vision blurred—Methotrexate—systemic scleroderma	0.000778	0.00105	CcSEcCtD
Diazoxide—Anorexia—Prednisone—systemic scleroderma	0.000768	0.00104	CcSEcCtD
Diazoxide—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000766	0.00104	CcSEcCtD
Diazoxide—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000756	0.00102	CcSEcCtD
Diazoxide—Rash—Mycophenolate mofetil—systemic scleroderma	0.00075	0.00102	CcSEcCtD
Diazoxide—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000749	0.00101	CcSEcCtD
Diazoxide—Headache—Mycophenolate mofetil—systemic scleroderma	0.000745	0.00101	CcSEcCtD
Diazoxide—Malaise—Methotrexate—systemic scleroderma	0.000744	0.00101	CcSEcCtD
Diazoxide—Leukopenia—Methotrexate—systemic scleroderma	0.000739	0.001	CcSEcCtD
Diazoxide—Insomnia—Prednisone—systemic scleroderma	0.000729	0.000988	CcSEcCtD
Diazoxide—Paraesthesia—Prednisone—systemic scleroderma	0.000724	0.000981	CcSEcCtD
Diazoxide—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000706	0.000957	CcSEcCtD
Diazoxide—Chest pain—Methotrexate—systemic scleroderma	0.000703	0.000952	CcSEcCtD
Diazoxide—Decreased appetite—Prednisone—systemic scleroderma	0.000701	0.000949	CcSEcCtD
Diazoxide—Discomfort—Methotrexate—systemic scleroderma	0.000694	0.000941	CcSEcCtD
Diazoxide—Feeling abnormal—Prednisone—systemic scleroderma	0.000664	0.0009	CcSEcCtD
Diazoxide—Thrombocytopenia—Methotrexate—systemic scleroderma	0.00066	0.000894	CcSEcCtD
Diazoxide—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000659	0.000893	CcSEcCtD
Diazoxide—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000651	0.000882	CcSEcCtD
Diazoxide—Anorexia—Methotrexate—systemic scleroderma	0.000642	0.00087	CcSEcCtD
Diazoxide—Abdominal pain—Prednisone—systemic scleroderma	0.000637	0.000863	CcSEcCtD
Diazoxide—Body temperature increased—Prednisone—systemic scleroderma	0.000637	0.000863	CcSEcCtD
Diazoxide—Hypotension—Methotrexate—systemic scleroderma	0.00063	0.000853	CcSEcCtD
Diazoxide—Insomnia—Methotrexate—systemic scleroderma	0.000609	0.000826	CcSEcCtD
Diazoxide—Paraesthesia—Methotrexate—systemic scleroderma	0.000605	0.00082	CcSEcCtD
Diazoxide—Hypersensitivity—Prednisone—systemic scleroderma	0.000594	0.000805	CcSEcCtD
Diazoxide—Decreased appetite—Methotrexate—systemic scleroderma	0.000586	0.000793	CcSEcCtD
Diazoxide—Asthenia—Prednisone—systemic scleroderma	0.000578	0.000784	CcSEcCtD
Diazoxide—Pain—Methotrexate—systemic scleroderma	0.000576	0.000781	CcSEcCtD
Diazoxide—Pruritus—Prednisone—systemic scleroderma	0.00057	0.000773	CcSEcCtD
Diazoxide—Feeling abnormal—Methotrexate—systemic scleroderma	0.000555	0.000752	CcSEcCtD
Diazoxide—Diarrhoea—Prednisone—systemic scleroderma	0.000552	0.000747	CcSEcCtD
Diazoxide—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000551	0.000746	CcSEcCtD
Diazoxide—Dizziness—Prednisone—systemic scleroderma	0.000533	0.000722	CcSEcCtD
Diazoxide—Abdominal pain—Methotrexate—systemic scleroderma	0.000533	0.000722	CcSEcCtD
Diazoxide—Body temperature increased—Methotrexate—systemic scleroderma	0.000533	0.000722	CcSEcCtD
Diazoxide—Vomiting—Prednisone—systemic scleroderma	0.000513	0.000694	CcSEcCtD
Diazoxide—Rash—Prednisone—systemic scleroderma	0.000508	0.000689	CcSEcCtD
Diazoxide—Dermatitis—Prednisone—systemic scleroderma	0.000508	0.000688	CcSEcCtD
Diazoxide—Headache—Prednisone—systemic scleroderma	0.000505	0.000684	CcSEcCtD
Diazoxide—Hypersensitivity—Methotrexate—systemic scleroderma	0.000496	0.000672	CcSEcCtD
Diazoxide—Asthenia—Methotrexate—systemic scleroderma	0.000483	0.000655	CcSEcCtD
Diazoxide—Nausea—Prednisone—systemic scleroderma	0.000479	0.000649	CcSEcCtD
Diazoxide—Pruritus—Methotrexate—systemic scleroderma	0.000477	0.000646	CcSEcCtD
Diazoxide—Diarrhoea—Methotrexate—systemic scleroderma	0.000461	0.000625	CcSEcCtD
Diazoxide—Dizziness—Methotrexate—systemic scleroderma	0.000445	0.000604	CcSEcCtD
Diazoxide—Vomiting—Methotrexate—systemic scleroderma	0.000428	0.00058	CcSEcCtD
Diazoxide—Rash—Methotrexate—systemic scleroderma	0.000425	0.000576	CcSEcCtD
Diazoxide—Dermatitis—Methotrexate—systemic scleroderma	0.000424	0.000575	CcSEcCtD
Diazoxide—Headache—Methotrexate—systemic scleroderma	0.000422	0.000572	CcSEcCtD
Diazoxide—Nausea—Methotrexate—systemic scleroderma	0.0004	0.000542	CcSEcCtD
